What Happened?
Cambridge, MA-based Cyteir-Therapeutics Appointed Markus Renschler as President and Chief Executive Officer
Date of management change: January 15, 2018
Cambridge, MA-based Cyteir-Therapeutics Appointed Markus Renschler as President and Chief Executive Officer
Cyteir is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA damage response biology to advance a pipeline of novel drug candidates that selectively target key cancer vulnerabilities. Cyteir`s wholly owned lead compound, CYT-0851, is a potent and selective, oral investigational drug currently in a Phase 1/2 clinical trial for hematologic and solid tumors.
Markus Renschler is President and Chief Executive Officer at Cyteir Therapeutics. Previously, Markus held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Williams Jennifer, Schlenker Arthur, Bucknell Bryce, Dalal Rajiv, Rayer Scott, Shelton Joni, Gangwani Kishore, Dave Chhaya, Podeschi Darrin, Chung Jay, Repert Melissa
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.